Aurora Therapeutics has emerged from stealth with $16 million in funding from Menlo Ventures to expand the potential of gene ...
Friday, Aurora Therapeutics debuted with $16 million in seed capital from Menlo Ventures. Its goal: To develop the industry’s ...
Co-founded by Jennifer Doudna and Fyodor Urnov, the company intends to simultaneously develop many gene editing treatments for rare conditions by using the agency’s “plausible mechanism” pathway.
Nicole and Kyle Muldoon with their child, KJ, who received a CRISPR gene editing therapy at Children's Hospital of Philadelphia. From the San Francisco Business Times. Months after helping manufacture ...
Aurora Therapeutics today announced its official launch to transform personalized gene editing from a one-patient breakthrough into a scalable model capable of bringing therapies to millions of ...
The U.S. Patent and Trademark Office plans to grant the UC Berkeley two patents related to CRISPR gene editing — a significant achievement for the university, which has been in a years-long patent ...
BERKELEY, Calif. -- UC Berkeley Professor Jennifer Doudna won the Nobel Prize in Chemistry Wednesday morning along with French Microbiologist Emmanuelle Charpentier for their work on genome editing.
A spinout from the lab of Nobel laureate Jennifer Doudna has raised $82 million to create drugs that, with a single infusion, can turn patients’ immune cells into cancer- and autoimmune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results